6-32192168-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001276501.2(GPSM3):c.125C>T(p.Pro42Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000635 in 1,510,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001276501.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPSM3 | NM_001276501.2 | c.125C>T | p.Pro42Leu | missense_variant | 2/4 | ENST00000375040.8 | |
GPSM3 | NM_022107.3 | c.125C>T | p.Pro42Leu | missense_variant | 6/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPSM3 | ENST00000375040.8 | c.125C>T | p.Pro42Leu | missense_variant | 2/4 | 1 | NM_001276501.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151952Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000689 AC: 12AN: 174138Hom.: 0 AF XY: 0.0000655 AC XY: 6AN XY: 91610
GnomAD4 exome AF: 0.0000655 AC: 89AN: 1359030Hom.: 0 Cov.: 30 AF XY: 0.0000662 AC XY: 44AN XY: 664946
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151952Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74192
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 24, 2024 | The c.125C>T (p.P42L) alteration is located in exon 6 (coding exon 2) of the GPSM3 gene. This alteration results from a C to T substitution at nucleotide position 125, causing the proline (P) at amino acid position 42 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at